Contents of this document
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | ¥1,004,749 million (YoY +101.9%) |
| Operating profit | ¥13,207 million (YoY +88.1%) |
| Ordinary income | ¥13,534 million (YoY +86.7%) |
| Net income | ¥10,130 million (YoY +97.8%) |
| Gross Profit Margin | Rate 9.7% / Year on year against the same period last year ▲0.1p |
| Operating profit margin | Rate 1.3% / Year on year against the same period last year ▲0.2p |
| Selling, general and administrative expenses | ¥84,123 million |
| Full-year earnings forecast | Net Sales ¥1,030,000 million / Operating profit ¥11,000 million / Ordinary income ¥10,500 million / Profit attributable to owners of the parent ¥7,000 million / EBITDA ¥16,552 million / ROE 5.6 % |
| Segment results | By category H&B Net Sales ¥314,577 million / Year on year against the same period last year 102.6 / Paper products Net Sales ¥195,597 million / Year on year against the same period last year 102.4 / Pet Net Sales ¥191,693 million / Year on year against the same period last year 102.5 / Household Net Sales ¥140,292 million / Year on year against the same period last year 101 / Home Care Net Sales ¥63,058 million / Year on year against the same period last year 100.3 / Household products Net Sales ¥21,449 million / Year on year against the same period last year 103.6 / Other Not disclosed / By business type Drugstores Net Sales ¥522,924 million / Year on year against the same period last year 102.3 / Home centers Net Sales ¥137,760 million / Year on year against the same period last year 98.1 / Supermarkets Net Sales ¥110,086 million / Year on year against the same period last year 100 / Discount stores Net Sales ¥82,189 million / Year on year against the same period last year 106.6 / GMS Net Sales ¥34,593 million / Year on year against the same period last year 90.8 / Other Net Sales ¥117,195 million / Year on year against the same period last year 107.3 |
| Breakdown of Factors Affecting the Change | Operating profit, fiscal year ended March 2026 Net Sales ¥1,808 million / Gross Profit Margin ¥-700 million / Personnel Expenses ¥-638 million / Logistics Costs ¥-1,383 million / Occupancy and property expenses ¥-867 million |
| Key KPIs | EBITDA ¥18,069 million / ROE 8.4 % / Revenue surpassing ¥1 trillion Reported as a numerical figure |
| Medium-term management plan targets | Only references profit improvement, growth strategies and strengthening the business foundation under the new Medium-Term Management Plan 2030. Specific target figures and target years are Not disclosed |
| Financial targets | ROE Actual results 8.4% / Fiscal year ending March 2027: plan 5.6% |
| Annual Dividend | Fiscal year ending March 2026 Annual ¥112 / Interim ¥56 / End of period ¥56 / Forecast for the fiscal year ending March 2027 Annual ¥112 / Interim ¥56 / End of period ¥56 |
| Payout ratio | Policy Targeting 30% / Forecast for the fiscal year ending March 2027 53.5% |
| New initiatives | Advancing the growth strategies and business foundation strengthening initiatives under the new Medium-Term Management Plan 2030, and increasing growth investment for the future |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue was driven by the H&B and pet categories, higher product prices, and exclusive and priority-distribution products. However, profits were weighed down by a decline in the gross profit margin due to higher center fees and rebates, increased SG&A expenses resulting from inflation and higher personnel and logistics costs, and higher interest expenses due to rising interest rates.